Holen Sie sich die Stockscreener-App
25.57
5.54%
-1.50
Handel nachbörslich:
25.08
-0.49
-1.92%
Schlusskurs vom Vortag:
$27.07
Offen:
$26.32
24-Stunden-Volumen:
1.30M
Relative Volume:
0.36
Marktkapitalisierung:
$2.05B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-11.89
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
+2.28%
1M Leistung:
-8.61%
6M Leistung:
+452.27%
1J Leistung:
+344.70%
1-Tages-Spanne:
$24.60
$26.86
1-Wochen-Bereich:
$23.85
$27.38
52-Wochen-Spanne:
$2.86
$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Vergleichen Sie OLMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
25.57 | 2.17B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-08 | Eingeleitet | Guggenheim | Buy |
| 2025-08-12 | Bestätigt | Citigroup | Buy |
| 2024-04-02 | Eingeleitet | Goldman | Buy |
| 2024-01-30 | Eingeleitet | Citigroup | Buy |
| 2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-05 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-12-14 | Eingeleitet | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Will Olema Pharmaceuticals Inc. stock pay special dividendsGDP Growth & Expert Verified Stock Movement Alerts - ulpravda.ru
UBS Initiates Coverage on Olema Pharmaceuticals (OLMA) with a 'B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Piper Sandler - MarketBeat
Piper Sandler initiates Olema Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Canada
UBS initiates Olema Pharmaceuticals stock with Buy rating, $45 target By Investing.com - Investing.com Canada
Olema Oncology (OLMA) Targeted for Growth with $60 Price Objecti - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Olema Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 2,881 Shares of Stock - MarketBeat
Olema Pharmaceuticals director Harmon sells $82,194 in stock By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals director Harmon sells $82,194 in stock - Investing.com India
Olema Pharmaceuticals Earnings Notes - Trefis
Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open - ts2.tech
Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday - ts2.tech
Will Olema Pharmaceuticals’ (OLMA) Index Debut Quietly Redefine Its Standing Among Biotech Investors? - simplywall.st
Olema: 'Strong Buy' Maintained On OPERA-02 Trial Initiation & Additional Shots On Goal - Seeking Alpha
Olema Pharmaceuticals Insider Sold Shares Worth $1,553,544, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,873,109, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,530,148, According to a Recent SEC Filing - marketscreener.com
Olema pharma chief medical officer sells shares for $7.5m By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells $7,872,504.00 in Stock - MarketBeat
Naseem Zojwalla Sells 100,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
David Myles Sells 51,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals ch. discov. Myles C. sells $1.55m in stock - Investing.com Australia
Olema pharma director Clark sells $7.87 million in shares - Investing.com India
Olema pharma director Clark sells $7.87 million in shares By Investing.com - Investing.com UK
Olema pharma chief medical officer sells shares for $7.5m - Investing.com
Olema Pharmaceuticals (OLMA): Reassessing Valuation After S&P Biotechnology Select Industry Index Inclusion - Sahm
6 people charged in $41M insider trading scheme tied to 2 biotechs - Fierce Biotech
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - MSN
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Olema Pharmaceuticals (OLMA) price target increased by 25.00% to 46.54 - MSN
How Olema Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
Aug Rallies: Will Olema Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Gainers & Precise Swing Trade Entry Alerts - Улправда
Why Olema Pharmaceuticals Inc. stock is favored by pension fundsJuly 2025 Closing Moves & Verified Momentum Stock Watchlist - Улправда
Why Olema Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Intraday Action & Stock Portfolio Risk Control - Улправда
Officer Myles Files To Sell 51,000 Of Olema Pharmaceuticals Inc [OLMA] - TradingView — Track All Markets
Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025 - ts2.tech
Is Olema Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Trade Report & Detailed Earnings Play Strategies - DonanımHaber
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 3.5%Time to Sell? - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastMomentum Trading Signals & Fast Profit Trading Tips - earlytimes.in
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):